| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SELECTA BIOSCIENCES INC | 1,924,151 | 26,919,000 | 28.90% | ||
| 2 | T2 BIOSYSTEMS INC | 1,875,524 | 14,798,000 | 15.89% | ||
| 3 | TREVENA INC | 2,270,319 | 14,303,000 | 15.35% | ||
| 4 | GENOCEA BIOSCIENCES INC | 1,968,606 | 8,071,000 | 8.66% | ||
| 5 | PULMATRIX INC | 3,607,996 | 7,072,000 | 7.59% | ||
| 6 | CERULEAN PHARMA INC | 3,287,529 | 6,970,000 | 7.48% | ||
| 7 | Life Technologies Corp | 1,827,992 | 5,082,000 | 5.46% | ||
| 8 | OCULAR THERAPEUTIX INC | 998,713 | 4,944,000 | 5.31% | ||
| 9 | FATE THERAPEUTICS INC COM | 2,473,186 | 4,204,000 | 4.51% | ||
| 10 | BIND THERAPEUTICS INC | 2,018,253 | 789,000 | 0.85% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-018588, filed 2016.07.28).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
